Aflibercept Injection Into the Vitreous Body of the Eye: Study to Learn More About Patient Relevant Outcomes, Real World Treatment Patterns and How Well the Treatment Works for Patients Suffering From Abnormal Growth of New Blood Vessels Under the Retina.
Clinical trial NCT03714308 · COMPLETED
Trial details
- NCT number
- NCT03714308
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-01-28
- Primary completion
- 2023-03-06
- Enrollment
- 554
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.